期刊文献+

Survivin在羟基喜树碱诱导胃癌细胞株BGC-823凋亡过程中的变化及其意义

Change of survivin gene expression in gastric cancer cell line BGC-823 induced by hydroxycamptothecine
下载PDF
导出
摘要 背景与目的抗肿瘤药物主要通过诱导细胞凋亡发挥作用,化疗耐药性产生可能与凋亡相关基因表达异常有关。本文探讨凋亡抑制基因survivin在胃癌化疗耐药中的作用。方法21.96mmol/L羟基喜树碱处理胃癌细胞株BGC-823,FCM及TUNEL检测细胞凋亡,RT-PCR和免疫组化检测survivin表达。结果与对照组相比,羟基喜树碱能诱导胃癌细胞株BGC-823凋亡。[凋亡率FCM(12.68±0.17)%vs(3.35±0.13)%(P<0.01),凋亡指数(AI)TUNEL法(16.00±1.23)%vs(2.78±0.84)%(P<0.01)],同时诱导BGC-823细胞Survivin表达上调[mRNA(1.489±0.041)vs(0.756±0.037)(P<0.05),蛋白(0.928±0.046)vs(0.303±0.032)(P<0.01)]。结论Survivin基因可能和胃癌细胞获得性化疗耐药有关。 Background and purpose: The antitumor drugs produce a marked effect through the induction of apoptosis. The resistance to chemotherapy has been found to be associated with abnormal expression of genes related to apoptosis. We designed this experiment to investigate the role of survivin gene in the resistance to chemotherapy. Methods: After being treated with Hydroxycamptothecine (OPT, 21.96mmol/L), the apoptosis in gastric cancer cell line BGC-823 cells were evaluated by either flow cytometry(FCM) or the terminal deoxynucleotidy transfer mediated dUTP-biotin nick end labeling ( TUNEL). The expression of Survivin was detected by reverse transcription- Polymerase chain reaction(RT-PCR) and immunohistochemistry. Results: Compared to control group, the OPT can induced apoptosis in BGC-823[ ( 12.68 ±0.17) % vs ( 3.35 ± 0.13) % by FCM, ( 16.00 ± 1.23) % vs (2.78 ± 0.84) % by TUNEL[, OPT could upregulate survivin expression in BGC-823 cells ( 1. 489 ±0. 041) % vs (0. 756±0. 037) % in terms of level of mRNA, (0. 928 ±0. 046) vs (0.303±0. 032) in terms of protein expression). Conclusions: The survivin gene may be associated to the resistance to chemotherapy through the induction of gene expression.
作者 陈轩 王子卫
出处 《中国癌症杂志》 CAS CSCD 2006年第9期741-743,共3页 China Oncology
关键词 SURVIVIN 胃肿瘤 羟基喜树碱 化疗耐药 survivin gastric neoplasm hydroxycamptothecine chemotherapy tolerance
  • 相关文献

参考文献8

  • 1Ikeguchi M,Kaibara N.Changes in survivin messenger RNA level during cisplatin treatment in gastric cancer[J].Int J Mol Med,2001,8(6):661-666.
  • 2陈振勇,陈道达,朱鹏,郑海.生存蛋白Survivin在人胃癌组织中的表达[J].肿瘤防治杂志,2004,11(8):823-825. 被引量:4
  • 3Hengartner MO.The biochemistry of apoptosis[J].Nature,2000,407 (6805):770-776.
  • 4Tamm I,Wang Y,Sausville E,et al.IAP-family protein survivin inhibits caspas activity and apoptosis induced by Fas (CD95),Bax,caspas,and anticancer drugs[J].Cancer Res,1998,58(23):5315-5320.
  • 5Suzuki A,Ito T,Kawano H,et al.Survivin initiates procaspas 3/P21 complex formation as areslat of interaction with CDK4 to resist Fas-mediated cell death[J].Oncongene,2000,19(10):1346-1353.
  • 6Du CY,Fang M,Li YC,et al.Smac,a mitochondrial protein that promotes cytochrome C-dependent caspas activation by eliminating IAP inhibition[J].Cell,2000,102(1):33-42.
  • 7Verhagen AM,Ekert PG,Pakusch M,et al.Identification of Diablo,a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins[J].Cell,2000,102(1):43-53.
  • 8赵君宁,张振玉,孙士其,潘峰,罗新华,王劲松.Survivin在胃癌中的表达及其与COX-2相关性的研究[J].中国癌症杂志,2004,14(1):15-18. 被引量:16

二级参考文献11

  • 1Grazia ambrosini, Altieri, Emily Y, et al. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma[J]. Nature medicine ,1997, 3(8):917-921.
  • 2Suzuki A, Ito T, Kawano H ,et al. Survivin initiates procapase 3/P21 complex formation as a resμlt of interaction with CDK4 to resist Fas-mediated cell death[J]. Oncogene,2000,19(10):1346-1353.
  • 3Takamizawa S, Scott D, Wen J, et al.The survivin:fas ratio in pediatric renal tumors[J].J Pediatr Surg ,2001,36(1):37-42.
  • 4I keguchi M, Kaibana N. Changes in survivin messenger RNA level during cisplatin treatment in gastric cancer[J]. Int J Mol Med,2001, 8(6):661-666.
  • 5Yagihashi A, Asanuma K,Nakamura M,et al.Detection of anti-survivin antibody in gastrointestinal cancer patients[J].Clin Chem, 2001,47(9):1729-1731.
  • 6Zhao J, Tenev T,Martins, et al. The ubiquitin proteasome pathway regulates survivin degradation in a cell cycle-dependent manner[J]. J Cell Sci,2000,113(23):4363-4371.
  • 7Yu J, Leung W K, Ebert M P, et al. Increased expression of survivin in gastric cancer patients and in first degree relatives[J]. Br J Cancer (Scotland), 2002, 87(1):91-97.
  • 8Okada E, Murai Y, Matsui K. Survivin expression in tumor cell mulei is predictive of a favorable prognosis in gastric cancer patients[J]. Cancer Lett, 2001,163(1):109-116.
  • 9Andersen M H,Pedersen L O,Becker J C,et al. Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients[J]. Cancer Res,2001,61(16):5964-5968.
  • 10Kanwar J R,Shen W P,Kanwar R K. et al .Effects of survivin antagonists on growth of established tumors and b7-1 immunogene therapy[J]. J Natl Cancer Inst,2001,93(20):1541-1552.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部